Alpha Cognition Inc.

ACOG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001655923

Price chart

Open-market purchases and sales by ACOG insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 16, 20265:57 PM ETSep 14 – Sep 16, 2026Opaleye Management Inc.10% OwnerPPurchaseCommon Stock, no par value+123.92K$8.5743+$1.06M3.17M+4.1%SEC
Aug 24, 20262:52 PM ETAug 21, 2026Wills Robert JamesDirectorPPurchaseCommon Shares+10K$9.62+$96.2K32.24K+45.0%SEC
Aug 4, 20264:50 PM ETJul 31 – Aug 3, 2026Opaleye Management Inc.10% OwnerPPurchaseCommon Stock, no par value+52.9K$7.9958+$422.98K3.05M+1.8%SEC
Jul 28, 20264:05 PM ETJul 24, 2026Opaleye Management Inc.10% OwnerPPurchaseCommon Stock, no par value+130$7.90+$1.03K3M0.0%SEC
Jul 24, 20264:05 PM ETJul 22 – Jul 23, 2026Opaleye Management Inc.10% OwnerPPurchaseCommon Stock, no par value+200.09K$7.8241+$1.57M3M+7.2%SEC

The largest institutional positions in ACOG at the end of Q2 2026.

Institutions holding ACOG in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Opaleye Management Inc.2,895,467$20.91M1.89%+333,517+13.0%Added
Solas Capital Management, LLC1,924,617$13.9M7.45%00.0%Unchanged
AWM Investment Company, Inc.1,672,168$12.07M1.05%00.0%Unchanged
Cable Car Capital LLC1,382,339$9.98M0.21%00.0%Unchanged
Ikarian Capital, LLC836,259$6.04M0.99%−220,000−20.8%Reduced